% alzhub.org library filter
% Source: https://alzhub.org/research?author=Arbizu+J
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{rabinovici2025-39776249,
  author  = {Rabinovici, G. D. and Knopman, D. S. and Arbizu, J. and Benzinger, T. L. S. and Donohoe, K. J. and Hansson, O. and Herscovitch, P. and Kuo, P. H. and Lingler, J. H. and Minoshima, S. and others},
  title   = {{Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.14338},
  pmid    = {39776249},
  url     = {https://doi.org/10.1002/alz.14338}
}

@article{chetelat2020-33098804,
  author  = {Chételat, G. and Arbizu, J. and Barthel, H. and Garibotto, V. and Law, I. and Morbelli, S. and van de Giessen, E. and Agosta, F. and others},
  title   = {{Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias}},
  journal = {The Lancet. Neurology},
  year    = {2020},
  doi     = {10.1016/s1474-4422(20)30314-8},
  pmid    = {33098804},
  url     = {https://doi.org/10.1016/s1474-4422(20)30314-8}
}

@article{perezgrijalba2019-31787105,
  author  = {Pérez-Grijalba, V. and Arbizu, J. and Romero, J. and Prieto, E. and Pesini, P. and Sarasa, L. and Guillen, F. and Monleón, I. and others},
  title   = {{Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2019},
  doi     = {10.1186/s13195-019-0549-1},
  pmid    = {31787105},
  url     = {https://doi.org/10.1186/s13195-019-0549-1}
}

@article{arbizu2015-26099942,
  author  = {Arbizu, J. and García-Ribas, G. and Carrió, I. and Garrastachu, P. and Martínez-Lage, P. and Molinuevo, J. L.},
  title   = {{Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus}},
  journal = {Revista espanola de medicina nuclear e imagen molecular},
  year    = {2015},
  doi     = {10.1016/j.remn.2015.03.002},
  pmid    = {26099942},
  url     = {https://doi.org/10.1016/j.remn.2015.03.002}
}

@article{perezgrijalba2019-30569084,
  author  = {Pérez-Grijalba, V. and Romero, J. and Pesini, P. and Sarasa, L. and Monleón, I. and San-José, I. and Arbizu, J. and Martínez-Lage, P. and others},
  title   = {{Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2019},
  doi     = {10.14283/jpad.2018.41},
  pmid    = {30569084},
  url     = {https://doi.org/10.14283/jpad.2018.41}
}

@article{arbizu2013-23715905,
  author  = {Arbizu, J. and Prieto, E. and Martínez-Lage, P. and Martí-Climent, J. M. and García-Granero, M. and Lamet, I. and Pastor, P. and Riverol, M. and others},
  title   = {{Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia}},
  journal = {European journal of nuclear medicine and molecular imaging},
  year    = {2013},
  doi     = {10.1007/s00259-013-2458-z},
  pmid    = {23715905},
  url     = {https://doi.org/10.1007/s00259-013-2458-z}
}